Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CryoLife CE-marks tissue-engineered pulmonary heart valve:

This article was originally published in Clinica

Executive Summary

CryoLife has CE-marked for sale in Europe its second tissue-engineered heart valve. The SynerGraft model 700 pulmonary heart valve involves the use of a porcine pulmonary heart valve that has been depopulated of its own cells, providing a collagen matrix that can be colonised with the recipient's own cells. The Atlanta, Georgia firm gained European marketing clearance for its SynerGraft model 500 aortic valve last year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel